Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9458076rdf:typepubmed:Citationlld:pubmed
pubmed-article:9458076lifeskim:mentionsumls-concept:C0003451lld:lifeskim
pubmed-article:9458076lifeskim:mentionsumls-concept:C0025932lld:lifeskim
pubmed-article:9458076lifeskim:mentionsumls-concept:C0010843lld:lifeskim
pubmed-article:9458076lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9458076lifeskim:mentionsumls-concept:C2931822lld:lifeskim
pubmed-article:9458076lifeskim:mentionsumls-concept:C0286079lld:lifeskim
pubmed-article:9458076pubmed:issue3lld:pubmed
pubmed-article:9458076pubmed:dateCreated1998-2-24lld:pubmed
pubmed-article:9458076pubmed:abstractTextThe effect of the antiviral agent (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (cidofovir) on the EBV-associated tumor nasopharyngeal carcinoma (NPC) was evaluated in NPC xenografts in athymic mice. Intratumoral injection arrested tumor growth within 1 week, and by 4 weeks, tumors regressed to 8-75% (39 +/- 33%) of the original size, whereas control tumors injected with PBS grew to 282 +/- 25% of the original size. Ganciclovir slowed but did not arrest or cause regression of tumor growth. A striking antitumor effect was also produced by systemic administration; at 4 weeks, tumors were 79 +/- 49% of the original size, compared with 635 +/- 91% for the controls. Widespread apoptosis was detected after treatment for 2-6 days in C15 as well as two other NPC xenografts, C17 and C18; the latter NPCs have mutations in the p53 gene. These data indicate that cidofovir induces rapid cell death through apoptosis in EBV-transformed epithelial cells.lld:pubmed
pubmed-article:9458076pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:languageenglld:pubmed
pubmed-article:9458076pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:citationSubsetIMlld:pubmed
pubmed-article:9458076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9458076pubmed:statusMEDLINElld:pubmed
pubmed-article:9458076pubmed:monthFeblld:pubmed
pubmed-article:9458076pubmed:issn0008-5472lld:pubmed
pubmed-article:9458076pubmed:authorpubmed-author:De ClercqEElld:pubmed
pubmed-article:9458076pubmed:authorpubmed-author:PaganoJ SJSlld:pubmed
pubmed-article:9458076pubmed:authorpubmed-author:Raab-TraubNNlld:pubmed
pubmed-article:9458076pubmed:authorpubmed-author:SadlerRRlld:pubmed
pubmed-article:9458076pubmed:authorpubmed-author:NeytsJJlld:pubmed
pubmed-article:9458076pubmed:issnTypePrintlld:pubmed
pubmed-article:9458076pubmed:day1lld:pubmed
pubmed-article:9458076pubmed:volume58lld:pubmed
pubmed-article:9458076pubmed:ownerNLMlld:pubmed
pubmed-article:9458076pubmed:authorsCompleteYlld:pubmed
pubmed-article:9458076pubmed:pagination384-8lld:pubmed
pubmed-article:9458076pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:meshHeadingpubmed-meshheading:9458076-...lld:pubmed
pubmed-article:9458076pubmed:year1998lld:pubmed
pubmed-article:9458076pubmed:articleTitleThe antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.lld:pubmed
pubmed-article:9458076pubmed:affiliationLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill 27599-7295, USA.lld:pubmed
pubmed-article:9458076pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9458076pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9458076pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9458076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9458076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9458076lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9458076lld:pubmed